Physitrack Past Earnings Performance

Past criteria checks 0/6

Physitrack's earnings have been declining at an average annual rate of -25.7%, while the Healthcare Services industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 15.8% per year.

Key information

-25.73%

Earnings growth rate

-27.07%

EPS growth rate

Healthcare Services Industry Growth-11.69%
Revenue growth rate15.84%
Return on equity-35.88%
Net Margin-42.03%
Next Earnings Update31 Jul 2025

Recent past performance updates

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Nov 20
Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Recent updates

Subdued Growth No Barrier To Physitrack PLC (STO:PTRK) With Shares Advancing 28%

Jun 20
Subdued Growth No Barrier To Physitrack PLC (STO:PTRK) With Shares Advancing 28%

Is Physitrack (STO:PTRK) A Risky Investment?

Jun 01
Is Physitrack (STO:PTRK) A Risky Investment?

Physitrack PLC's (STO:PTRK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Apr 08
Physitrack PLC's (STO:PTRK) 26% Dip In Price Shows Sentiment Is Matching Revenues

Physitrack PLC's (STO:PTRK) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Feb 06
Physitrack PLC's (STO:PTRK) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Is Physitrack (STO:PTRK) A Risky Investment?

Feb 05
Is Physitrack (STO:PTRK) A Risky Investment?

Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Nov 20
Investors Shouldn't Be Too Comfortable With Physitrack's (STO:PTRK) Earnings

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13
Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Nov 13
Positive Sentiment Still Eludes Physitrack PLC (STO:PTRK) Following 28% Share Price Slump

Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Jun 15
Investors Aren't Entirely Convinced By Physitrack PLC's (STO:PTRK) Revenues

Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

May 09
Physitrack (STO:PTRK) Is Doing The Right Things To Multiply Its Share Price

Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

Apr 10
Physitrack (STO:PTRK) Has A Somewhat Strained Balance Sheet

Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Feb 29
Physitrack PLC (STO:PTRK) Could Be Riskier Than It Looks

Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Oct 12
Revenues Tell The Story For Physitrack PLC (STO:PTRK)

Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Aug 18
Why Physitrack PLC (STO:PTRK) Could Be Worth Watching

Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Jan 29
Be Wary Of Physitrack (STO:PTRK) And Its Returns On Capital

Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Oct 29
Physitrack (STO:PTRK) Will Be Hoping To Turn Its Returns On Capital Around

Revenue & Expenses Breakdown

How Physitrack makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OM:PTRK Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2516-700
31 Dec 2416-600
30 Sep 2415200
30 Jun 2415300
31 Mar 2415300
31 Dec 2315300
30 Sep 2315000
30 Jun 2314000
31 Mar 2314000
31 Dec 2213000
30 Sep 2211050
30 Jun 2210030
31 Mar 229-150
31 Dec 218-150
30 Nov 218-150
31 Aug 216-150
31 May 215140
28 Feb 214130
30 Nov 203110
30 Nov 191010
30 Nov 181010
30 Nov 170000
30 Nov 160000
30 Nov 150000
30 Nov 140000

Quality Earnings: PTRK is currently unprofitable.

Growing Profit Margin: PTRK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PTRK is unprofitable, and losses have increased over the past 5 years at a rate of 25.7% per year.

Accelerating Growth: Unable to compare PTRK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PTRK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-6.9%).


Return on Equity

High ROE: PTRK has a negative Return on Equity (-35.88%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/07 15:16
End of Day Share Price 2025/07/04 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Physitrack PLC is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rebecka GärderupABG Sundal Collier Sponsored
Joachim GunellDNB Carnegie
Jessica GrunewaldRedeye